H020 Enhancing multidisciplinary care for pre-manifest Huntington’s disease: insights from a neurology management clinic

<h3>Background</h3> Individuals with Huntington’s disease (HD) require care throughout disease course, regardless of pre-symptomatic testing status. Despite recommended follow-up after genetic counselling, barriers to accessing appropriate services during ‘pre-manifest’ HD frequently result in missed opportunities for timely healthcare interventions. Transition of individuals from Clinical Genetics to multidisciplinary care, and the role of neurology services prior to symptomatic disease, has been poorly studied. <h3>Aims</h3> This clinical audit sought to gain insight into demographics and the clinical journey of patients presenting to the newly established Neurology HD Clinic and their prior engagement with other specialist services. Methods Retrospective data collection and analysis was conducted to characterise patients attending the HD Neurology Clinic during January 2022 – April 2023. Qualitative review of individual cases sought to explore experiences of genetic counselling and pre-symptomatic testing. <h3>Results</h3> Patients with manifest HD represented 77.6% (n=45) of clinic attendees. Most patients had either undergone pre-symptomatic or diagnostic testing through Clinical Genetics, however past neurologist input was minimal. GP and community-based support provided 65% of referrals, but individual pathway analysis indicated that most patients who engaged with genetic counselling since the Neurology Clinic was established could access multidisciplinary care irrespective of a genetic or symptomatic diagnosis. <h3>Conclusions</h3> Specialist, interdisciplinary input is crucial before symptom onset to mitigate the impact of the disease progression, but not all at-risk patients were able to access neurology services. Joint coordination between Genetic Counsellors and Neurologists during pre-symptomatic testing could initiate and maintain patient relationships throughout disease stage, promoting equitable access to long-term support.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/jnnp-2024-ehdn.250
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

H020 Enhancing multidisciplinary care for pre-manifest Huntington’s disease: insights from a neurology management clinic

David G. Anderson, Lynsey E Marriott, Subhashini Crerar
Genetic Neurodegenerative Diseases
article

H020 Enhancing multidisciplinary care for pre-manifest Huntington’s disease: insights from a neurology management clinic

David G. Anderson, Lynsey E Marriott, Subhashini Crerar
article en

Abstract

<h3>Background</h3> Individuals with Huntington’s disease (HD) require care throughout disease course, regardless of pre-symptomatic testing status. Despite recommended follow-up after genetic counselling, barriers to accessing appropriate services during ‘pre-manifest’ HD frequently result in missed opportunities for timely healthcare interventions. Transition of individuals from Clinical Genetics to multidisciplinary care, and the role of neurology services prior to symptomatic disease, has been poorly studied. <h3>Aims</h3> This clinical audit sought to gain insight into demographics and the clinical journey of patients presenting to the newly established Neurology HD Clinic and their prior engagement with other specialist services. Methods Retrospective data collection and analysis was conducted to characterise patients attending the HD Neurology Clinic during January 2022 – April 2023. Qualitative review of individual cases sought to explore experiences of genetic counselling and pre-symptomatic testing. <h3>Results</h3> Patients with manifest HD represented 77.6% (n=45) of clinic attendees. Most patients had either undergone pre-symptomatic or diagnostic testing through Clinical Genetics, however past neurologist input was minimal. GP and community-based support provided 65% of referrals, but individual pathway analysis indicated that most patients who engaged with genetic counselling since the Neurology Clinic was established could access multidisciplinary care irrespective of a genetic or symptomatic diagnosis. <h3>Conclusions</h3> Specialist, interdisciplinary input is crucial before symptom onset to mitigate the impact of the disease progression, but not all at-risk patients were able to access neurology services. Joint coordination between Genetic Counsellors and Neurologists during pre-symptomatic testing could initiate and maintain patient relationships throughout disease stage, promoting equitable access to long-term support.

Children's Health Ireland at Crumlin (IE), Queen Elizabeth University Hospital (GB)
Openalex Percentile: Top 84%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

H020 Enhancing multidisciplinary care for pre-manifest Huntington’s disease: insights from a neurology management clinic — David G. Anderson, Lynsey E Marriott, et al. · (2024) | TGRS Research Map | TGRS